Understanding Immunity in Action: How Southern Research Advances Infectious Disease Science

Infectious diseases continue to evolve, presenting ongoing challenges for public health across the United States and abroad. From seasonal respiratory viruses to emerging and re-emerging pathogens, understanding how the immune system responds remains central to developing effective vaccines and therapeutics.

Progress in this space depends on more than tracking disease trends. It requires a deep, foundational understanding of immunology and the ability to translate that knowledge into practical solutions.

At Southern Research, that work is embedded into daily scientific efforts, connecting basic immune mechanisms with real-world disease impact.

Connecting Immunology to Today’s Health Challenges

Viruses such as influenza, respiratory syncytial virus, and SARS-CoV-2 continue to circulate widely, each presenting distinct challenges for immune protection and disease management. While these pathogens differ in structure and behavior, they share a common complexity: the immune system does not always respond in predictable or fully protective ways.

Southern Research focuses on understanding these immune dynamics at a fundamental level. By studying cytokine signaling, cellular immune responses, and antibody activity, researchers can better define what effective protection looks like and where vulnerabilities remain. Effective protection relies on the coordinated interaction between humoral immune responses, including antibody production, and cellular immune responses driven by T cells and other immune effectors. Evaluating both arms of the immune system provides a more complete understanding of the durability, breadth, and quality of protection against infectious diseases, while integrated immune profiling helps identify meaningful correlates of protection as well as potential immune-mediated risks.

This foundational insight informs the design and evaluation of vaccines and therapeutics aimed at reducing disease burden across diverse populations.

Measuring What Matters in Immune Response

Accurate measurement of immune activity is critical for evaluating whether a candidate intervention is likely to succeed. Southern Research applies a range of advanced platforms to characterize immune responses with precision.

Cytokine analysis helps identify patterns of inflammation and immune activation. Flow cytometry enables detailed profiling of immune cell populations and their functional states. Immunopathology studies provide insight into how immune responses contribute to both protection and disease. In addition to these approaches, Meso Scale Discovery (MSD) platforms enable highly sensitive, multiplexed quantification of cytokines and antibody responses, supporting detailed characterization of humoral immunity, while ELISPOT assays provide high-resolution insight into antigen-specific cellular immune responses, particularly T cell activation and function. Together, MSD and ELISPOT function as complementary, core platforms for immunological assessment by offering a dual view of soluble immune mediators and cell-mediated activity, strengthening the evaluation of immunogenicity and therapeutic potential for vaccines and immunotherapies.

Together, these tools create a comprehensive picture of how the body responds to infection, supporting more informed decision-making throughout the development process.

Applying Lessons from Ongoing Infectious Threats

Current infectious diseases continue to shape how scientists approach vaccine development. Influenza remains a moving target, requiring ongoing evaluation of immune breadth and cross-protection. RSV has underscored the importance of carefully assessing immune responses to avoid unintended consequences such as enhanced disease. COVID-19 has reinforced the need for scalable platforms and rapid, reliable data generation. These experiences highlight the importance of achieving a balanced immune response that incorporates both humoral and cellular immunity to optimize protection while minimizing risk, as well as the need for robust immunological assessment strategies that include complementary platforms such as MSD and ELISPOT.

Southern Research integrates these lessons into study design, ensuring that programs are grounded in both historical knowledge and present-day realities. This approach helps identify potential risks earlier and supports the development of safer, more effective interventions.

Bridging Discovery and Development

As the biotechnology landscape evolves, many organizations are generating promising candidates through computational or early-stage discovery approaches. Translating those candidates into meaningful biological data remains a critical step.

Southern Research provides the laboratory expertise needed to move from concept to validation. From early immunogenicity studies to advanced challenge models and immune profiling, we offer integrated support that aligns with the needs of modern drug and vaccine developers. These efforts incorporate both antibody-based and cell-based endpoints to ensure comprehensive evaluation of immune responses, with established platforms such as MSD and ELISPOT integrated throughout development workflows to generate consistent, high-quality data that informs key decisions.

The people you meet are the people running your studies. That continuity ensures that scientific insight is maintained throughout each stage of development.

Advancing Science to Improve Public Health

Efforts to combat infectious diseases rely on sustained collaboration and a commitment to scientific rigor. Southern Research’s work with federal partners and global health organizations reflects a broader mission to strengthen public health through applied science. Comprehensive immune evaluation strategies that address both humoral and cellular responses, supported by advanced assay platforms such as MSD and ELISPOT, enable a deeper understanding of immune protection and help accelerate the development of effective vaccines and therapeutics.

By focusing on the fundamentals of immunology and their relevance to current infectious diseases, Southern Research helps drive progress that is both immediate and enduring.

Understanding how the immune system responds to today’s threats is essential to shaping tomorrow’s solutions. At Southern Research, that understanding is at the core of every study, every platform, and every partnership. From cytokine analysis to immune profiling and challenge models, Southern Research provides the expertise to move your program forward with confidence. Contact our team to discuss your specific research needs.